Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News

Tekla Life Sciences Investors' stock was trading at $14.21 at the beginning of the year. Since then, HQL stock has decreased by 12.9% and is now trading at $12.38.
View the best growth stocks for 2023 here.

Tekla Life Sciences Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 25,700 shares, an increase of 71.3% from the August 15th total of 15,000 shares. Based on an average trading volume of 92,600 shares, the days-to-cover ratio is presently 0.3 days.
View Tekla Life Sciences Investors' Short Interest.

Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, August 15th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.32 per share on Friday, September 29th. This represents a $1.28 annualized dividend and a dividend yield of 10.34%. The ex-dividend date of this dividend is Thursday, August 24th.
Read our dividend analysis for HQL.

Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.28 per share and currently has a dividend yield of 10.30%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).

Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."

Tekla Life Sciences Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.18%), Allspring Global Investments Holdings LLC (1.18%), Cornerstone Advisors LLC (0.98%), Wolverine Asset Management LLC (0.90%), Flagship Harbor Advisors LLC (0.92%) and Raymond James & Associates (0.63%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz.
View institutional ownership trends.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HQL stock can currently be purchased for approximately $12.38.

Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $324.48 million.

Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.